These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 23957828)
1. The TWEAK-Fn14 system as a potential drug target. Wajant H Br J Pharmacol; 2013 Oct; 170(4):748-64. PubMed ID: 23957828 [TBL] [Abstract][Full Text] [Related]
3. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells. Ando T; Ichikawa J; Wako M; Hatsushika K; Watanabe Y; Sakuma M; Tasaka K; Ogawa H; Hamada Y; Yagita H; Nakao A Arthritis Res Ther; 2006; 8(5):R146. PubMed ID: 16945157 [TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 mediate cerebral ischemia-induced poly(ADP-ribose) polymerase-1 activation and neuronal death. Haile WB; Echeverry R; Wu F; Guzman J; An J; Wu J; Yepes M Neuroscience; 2010 Dec; 171(4):1256-64. PubMed ID: 20955770 [TBL] [Abstract][Full Text] [Related]
5. Studies of binding of tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) to fibroblast growth factor inducible 14 (Fn14). Fick A; Lang I; Schäfer V; Seher A; Trebing J; Weisenberger D; Wajant H J Biol Chem; 2012 Jan; 287(1):484-495. PubMed ID: 22081603 [TBL] [Abstract][Full Text] [Related]
6. Interaction of TWEAK with Fn14 leads to the progression of fibrotic liver disease by directly modulating hepatic stellate cell proliferation. Wilhelm A; Shepherd EL; Amatucci A; Munir M; Reynolds G; Humphreys E; Resheq Y; Adams DH; Hübscher S; Burkly LC; Weston CJ; Afford SC J Pathol; 2016 May; 239(1):109-21. PubMed ID: 26924336 [TBL] [Abstract][Full Text] [Related]
7. TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade. van Kuijk AW; Wijbrandts CA; Vinkenoog M; Zheng TS; Reedquist KA; Tak PP Ann Rheum Dis; 2010 Jan; 69(1):301-4. PubMed ID: 19147618 [TBL] [Abstract][Full Text] [Related]
8. The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system. Echeverry R; Wu F; Haile WB; Wu J; Yepes M J Neuroinflammation; 2012 Mar; 9():45. PubMed ID: 22394384 [TBL] [Abstract][Full Text] [Related]
9. TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways. Wang A; Zhang F; Xu H; Xu M; Cao Y; Wang C; Xu Y; Su M; Zhang M; Zhuge Y Mol Immunol; 2017 Jul; 87():67-75. PubMed ID: 28411440 [TBL] [Abstract][Full Text] [Related]
10. Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis. Dhruv H; Loftus JC; Narang P; Petit JL; Fameree M; Burton J; Tchegho G; Chow D; Yin H; Al-Abed Y; Berens ME; Tran NL; Meurice N J Biol Chem; 2013 Nov; 288(45):32261-32276. PubMed ID: 24056367 [TBL] [Abstract][Full Text] [Related]
11. Functional expression of TWEAK and the receptor Fn14 in human malignant ovarian tumors: possible implication for ovarian tumor intervention. Gu L; Dai L; Cao C; Zhu J; Ding C; Xu HB; Qiu L; Di W PLoS One; 2013; 8(3):e57436. PubMed ID: 23469193 [TBL] [Abstract][Full Text] [Related]
12. Inflammatory cytokines and survival factors from serum modulate tweak-induced apoptosis in PC-3 prostate cancer cells. Sanz AB; Sanchez-Niño MD; Carrasco S; Manzarbeitia F; Ruiz-Andres O; Selgas R; Ruiz-Ortega M; Gonzalez-Enguita C; Egido J; Ortiz A PLoS One; 2012; 7(10):e47440. PubMed ID: 23077618 [TBL] [Abstract][Full Text] [Related]
13. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression. Tran NL; McDonough WS; Savitch BA; Sawyer TF; Winkles JA; Berens ME J Biol Chem; 2005 Feb; 280(5):3483-92. PubMed ID: 15611130 [TBL] [Abstract][Full Text] [Related]
14. Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells. Roos A; Dhruv HD; Mathews IT; Inge LJ; Tuncali S; Hartman LK; Chow D; Millard N; Yin HH; Kloss J; Loftus JC; Winkles JA; Berens ME; Tran NL Oncotarget; 2017 Feb; 8(7):12234-12246. PubMed ID: 28103571 [TBL] [Abstract][Full Text] [Related]
15. TWEAK-independent Fn14 self-association and NF-κB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domain. Brown SA; Cheng E; Williams MS; Winkles JA PLoS One; 2013; 8(6):e65248. PubMed ID: 23750247 [TBL] [Abstract][Full Text] [Related]
16. Role of the TWEAK/Fn14 pathway in autoimmune diseases. Xu WD; Zhao Y; Liu Y Immunol Res; 2016 Feb; 64(1):44-50. PubMed ID: 26659091 [TBL] [Abstract][Full Text] [Related]
17. TWEAK/Fn14 signaling is required for liver regeneration after partial hepatectomy in mice. Karaca G; Swiderska-Syn M; Xie G; Syn WK; Krüger L; Machado MV; Garman K; Choi SS; Michelotti GA; Burkly LC; Ochoa B; Diehl AM PLoS One; 2014; 9(1):e83987. PubMed ID: 24416188 [TBL] [Abstract][Full Text] [Related]
18. TWEAK as a target for therapy in systemic lupus erythematosus. Leng RX; Pan HF; Qin WZ; Wang C; Chen LL; Tao JH; Ye DQ Mol Biol Rep; 2011 Jan; 38(1):587-92. PubMed ID: 20358293 [TBL] [Abstract][Full Text] [Related]
19. Roles of tumour necrosis factor-related weak inducer of apoptosis/fibroblast growth factor-inducible 14 pathway in lupus nephritis. Chen J; Wei L; Xia Y Nephrology (Carlton); 2017 Feb; 22(2):101-106. PubMed ID: 27786399 [TBL] [Abstract][Full Text] [Related]
20. The interaction between tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 promotes the recruitment of neutrophils into the ischemic brain. Haile WB; Echeverry R; Wu J; Yepes M J Cereb Blood Flow Metab; 2010 Jun; 30(6):1147-56. PubMed ID: 20068578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]